Fludarabine phosphate: a new active agent in hematologic malignancies.
Keating
M J
MJ
University of Texas M.D. Anderson Cancer Center, Houston 77030.
O'Brien
S
S
Plunkett
W
W
Robertson
L E
LE
Gandhi
V
V
Estey
E
E
Dimopoulos
M
M
Cabanillas
F
F
Kemena
A
A
Kantarjian
H
H
D000818:Animals; D002986:Clinical Trials as Topic; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D001084:Vidarabine Phosphate / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D001084:Vidarabine Phosphate; C042382:fludarabine phosphate